AGL Agilon Health inc

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 24, 2023

 

 

agilon health, inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware			001-40332	37-1915147
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
6210 E Hwy 290, Suite 450
Austin, Texas				78723
(Address of Principal Executive Offices)				(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 562 256-3800

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, par value $0.01 per share		AGL		The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

---

Item 5.07 Submission of Matters to a Vote of Security Holders.

agilon health, inc. (the "Company") held its annual meeting of stockholders on May 24, 2023. For more information on the following proposals submitted to stockholders, see the Company’s definitive proxy statement dated April 14, 2023. Below are the final voting results.

 

Proposal No. 1 - Election of Directors

 

The following four individuals were elected to the Company’s Board of Directors to serve as Class II directors until the Company’s 2026 annual meeting of stockholders and until their successors have been duly elected and qualified.

 

Name		Votes For		Votes Withheld		Votes Abstained		Broker Non-Votes
Ron Williams		357,488,559		34,999,837		36,434		7,391,970
Derek L. Strum		364,341,351		28,146,544		36,935		7,391,970
Diana L. McKenzie		391,812,524		675,590		36,716		7,391,970
Karen McLoughlin		366,785,937		25,702,674		36,219		7,391,970

 

Proposal No. 2 - Ratification of Independent Registered Public Accounting Firm

 

The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified.

 

Votes For		Votes Against		Votes Abstained
399,901,122		4,777		10,901

 

Proposal No. 3 - Non-Binding Vote on Executive Compensation

 

The stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company’s named executive officers.

 

Votes For		Votes Against		Votes Abstained		Broker Non-Votes
333,822,301		58,625,836		76,693		7,391,970

 

 

 

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			agilon health, inc.
Date:	May 25, 2023	By:	/s/ Timothy Bensley
			Timothy Bensley Chief Financial Officer

 

---